{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:38:18Z","timestamp":1786981098300,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","award":["Australian Government Research Training Program Scholarship"],"award-info":[{"award-number":["Australian Government Research Training Program Scholarship"]}],"id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Monash IVF Group","award":["PhD support stipend"],"award-info":[{"award-number":["PhD support stipend"]}]},{"DOI":"10.13039\/100014555","name":"Murdoch Children's Research Institute","doi-asserted-by":"publisher","award":["PhD top up scholarship"],"award-info":[{"award-number":["PhD top up scholarship"]}],"id":[{"id":"10.13039\/100014555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["Medical Research Future Fund #1196010"],"award-info":[{"award-number":["Medical Research Future Fund #1196010"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To evaluate live birth rates per embryo transfer where the primary indication for assisted reproduction was preimplantation genetic testing for monogenic conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All oocytes were fertilized using intracytoplasmic sperm injection. On days 5\u20137,\u2009~\u20095 trophectoderm cells were biopsied. Whole genome amplification was performed on biopsy samples, followed by a karyomapping protocol. Embryos underwent concurrent 24-chromosome screening. Outcomes included the number of stimulated cycles resulting in embryo biopsy, monogenic and aneuploidy screening results, embryo transfers, and clinical pregnancies and live births. Generalized Estimating Equations were used to analyze the relationship between binary clinical outcomes and fertility covariates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Between 2015 and 2022, the laboratory biopsied and tested 2344 embryos for monogenic indications, from 527 stimulated cycles. Eight hundred forty-nine biopsied embryos were euploid and low probability of the condition of interest. Five hundred and\u00a0thirteen embryos were transferred, resulting in 263 clinical pregnancies, and 230 live births. This translated to clinical pregnancy and live birth rates per embryo transfer of 51.3% (95% CI, 47.0\u201355.6%) and 44.8% (95% CI, 40.6\u201349.2%).<\/jats:p>\n                    <jats:p>\n                      Compared with patients undergoing preimplantation genetic testing without a subfertility factor, patients with a subfertility factor were 48% less likely to achieve a clinical pregnancy per embryo transfer (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009= \u2212\u20090.4797474,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.026) and 42% less likely to achieve a live birth (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u2009= \u2212\u20090.4172361,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.052).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Individuals accessing preimplantation genetic testing for monogenic conditions have higher clinical pregnancy and live birth rates than couples accessing in vitro fertilization for other indications such as subfertility. These findings confirm that preimplantation genetic testing is an effective reproductive option for Australian carrier individuals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10815-025-03416-6","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T04:13:42Z","timestamp":1741666422000},"page":"1567-1576","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["IVF success rates in individuals accessing preimplantation genetic testing for monogenic conditions (PGT-M): a single centre retrospective cohort study of 572 IVF cycles"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3506-9035","authenticated-orcid":false,"given":"Alice","family":"Poulton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melody","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"issue":"12","key":"3416_CR1","doi-asserted-by":"publisher","first-page":"6525","DOI":"10.3390\/ijms23126525","volume":"23","author":"I Condo","year":"2022","unstructured":"Condo I. Rare monogenic diseases: molecular pathophysiology and novel therapies. Int J Mol Sci. 2022;23(12):6525.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3416_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/ped4.12006","volume":"1","author":"Y Yao","year":"2017","unstructured":"Yao Y, Shen K. Monogenic diseases in respiratory medicine: clinical perspectives. Pediatr Investig. 2017;1(1):27\u201331.","journal-title":"Pediatr Investig"},{"issue":"12","key":"3416_CR3","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/sj.embor.7400860","volume":"7","author":"AM Leroi","year":"2006","unstructured":"Leroi AM. The future of neo-eugenics. EMBO Rep. 2006;7(12):1184\u20137.","journal-title":"EMBO Rep"},{"issue":"2","key":"3416_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s12687-011-0043-3","volume":"2","author":"DE Dye","year":"2011","unstructured":"Dye DE, Brameld KJ, Maxwell S, Goldblatt J, O\u2019Leary P. The impact of single gene and chromosomal disorders on hospital admissions in an adult population. J Community Genet. 2011;2(2):81\u201390.","journal-title":"J Community Genet"},{"issue":"4","key":"3416_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s12687-018-0376-2","volume":"9","author":"H Blencowe","year":"2018","unstructured":"Blencowe H, Moorthie S, Petrou M, Hamamy H, Povey S, Bittles A, et al. Rare single gene disorders: estimating baseline prevalence and outcomes worldwide. J Community Genet. 2018;9(4):397\u2013406.","journal-title":"J Community Genet"},{"issue":"1","key":"3416_CR6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12687-020-00484-2","volume":"12","author":"K Reumkens","year":"2021","unstructured":"Reumkens K, Tummers MHE, Severijns Y, Gietel-Habets JJG, van Kuijk SMJ, Aalfs CM, et al. Reproductive decision-making in the context of hereditary cancer: the effects of an online decision aid on informed decision-making. J Community Genet. 2021;12(1):101\u201310.","journal-title":"J Community Genet"},{"key":"3416_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bpobgyn.2016.10.010","volume":"39","author":"J Traeger-Synodinos","year":"2017","unstructured":"Traeger-Synodinos J. Pre-implantation genetic diagnosis. Best Pract Res Clin Obstet Gynaecol. 2017;39:74\u201388.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"Suppl 1","key":"3416_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/ijlh.12823","volume":"40","author":"C Vrettou","year":"2018","unstructured":"Vrettou C, Kakourou G, Mamas T, Traeger-Synodinos J. Prenatal and preimplantation diagnosis of hemoglobinopathies. Int J Lab Hematol. 2018;40(Suppl 1):74\u201382.","journal-title":"Int J Lab Hematol"},{"issue":"3","key":"3416_CR9","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/humrep\/dei382","volume":"21","author":"F Fiorentino","year":"2006","unstructured":"Fiorentino F, Biricik A, Nuccitelli A, De Palma R, Kahraman S, Iacobelli M, et al. Strategies and clinical outcome of 250 cycles of preimplantation genetic diagnosis for single gene disorders. Hum Reprod. 2006;21(3):670\u201384.","journal-title":"Hum Reprod"},{"issue":"2","key":"3416_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/cge.12411","volume":"87","author":"A Girardet","year":"2015","unstructured":"Girardet A, Ishmukhametova A, Willems M, Coubes C, Hamamah S, Anahory T, et al. Preimplantation genetic diagnosis for cystic fibrosis: the Montpellier center\u2019s 10-year experience. Clin Genet. 2015;87(2):124\u201332.","journal-title":"Clin Genet"},{"issue":"12","key":"3416_CR11","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/j.1471-0528.2006.01143.x","volume":"113","author":"J Grace","year":"2006","unstructured":"Grace J, El-Toukhy T, Scriven P, Ogilvie C, Pickering S, Lashwood A, et al. Three hundred and thirty cycles of preimplantation genetic diagnosis for serious genetic disease: clinical considerations affecting outcome. BJOG. 2006;113(12):1393\u2013401.","journal-title":"BJOG"},{"issue":"5","key":"3416_CR12","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1016\/j.fertnstert.2008.08.111","volume":"92","author":"C Gutierrez-Mateo","year":"2009","unstructured":"Gutierrez-Mateo C, Sanchez-Garcia JF, Fischer J, Tormasi S, Cohen J, Munne S, et al. Preimplantation genetic diagnosis of single-gene disorders: experience with more than 200 cycles conducted by a reference laboratory in the United States. Fertil Steril. 2009;92(5):1544\u201356.","journal-title":"Fertil Steril"},{"issue":"10","key":"3416_CR13","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3390\/medicina58101493","volume":"58","author":"A Patrikiou","year":"2022","unstructured":"Patrikiou A, Papadopoulou A, Noutsos C, Tzekis P, Koios N, Kourempeles I, et al. Clinical outcome, socioeconomic status and psychological constrains of patients undergoing preimplantation genetic testing (PGT) in Northern Greece. Medicina (Kaunas). 2022;58(10):1493.","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"3416_CR14","first-page":"107","volume":"21","author":"T Shaulov","year":"2020","unstructured":"Shaulov T, Zhang L, Chung JT, Son WY, Buckett W, Ao A. Outcomes of preimplantation genetic testing for single gene defects in a privately funded period and publicly funded period: a North-American single center experience. J Reprod Infertil. 2020;21(2):107\u201315.","journal-title":"J Reprod Infertil"},{"issue":"2","key":"3416_CR15","first-page":"99","volume":"23","author":"BF Zanetti","year":"2019","unstructured":"Zanetti BF, Braga D, Azevedo MC, Setti AS, Figueira RCS, Iaconelli A Jr, et al. Preimplantation genetic testing for monogenic diseases: a Brazilian IVF centre experience. JBRA Assist Reprod. 2019;23(2):99\u2013105.","journal-title":"JBRA Assist Reprod"},{"issue":"4","key":"3416_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2217\/WHE.09.28","volume":"5","author":"GD Adamson","year":"2009","unstructured":"Adamson GD. Global cultural and socioeconomic factors that influence access to assisted reproductive technologies. Womens Health (Lond). 2009;5(4):351\u20138.","journal-title":"Womens Health (Lond)"},{"issue":"6","key":"3416_CR17","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/j.fertnstert.2009.04.029","volume":"91","author":"GM Chambers","year":"2009","unstructured":"Chambers GM, Sullivan EA, Ishihara O, Chapman MG, Adamson GD. The economic impact of assisted reproductive technology: a review of selected developed countries. Fertil Steril. 2009;91(6):2281\u201394.","journal-title":"Fertil Steril"},{"issue":"Suppl 1","key":"3416_CR18","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1016\/j.ejogrb.2004.01.016","volume":"115","author":"B Behr","year":"2004","unstructured":"Behr B, Wang H. Effects of culture conditions on IVF outcome. Eur J Obstet Gynecol Reprod Biol. 2004;115(Suppl 1):S72\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"3416_CR19","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.rbmo.2014.12.004","volume":"30","author":"C Motteram","year":"2015","unstructured":"Motteram C, Vollenhoven B, Hope N, Osianlis T, Rombauts LJ. Live birth rates after combined adjuvant therapy in IVF-ICSI cycles: a matched case-control study. Reprod Biomed Online. 2015;30(4):340\u20138.","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"3416_CR20","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s10815-022-02407-1","volume":"39","author":"S Popkiss","year":"2022","unstructured":"Popkiss S, Horta F, Vollenhoven B, Green MP, Zander-Fox D. Calcium chloride dihydrate supplementation at ICSI improves fertilization and pregnancy rates in patients with previous low fertilization: a retrospective paired treatment cycle study. J Assist Reprod Genet. 2022;39(5):1055\u201364.","journal-title":"J Assist Reprod Genet"},{"issue":"6","key":"3416_CR21","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0015-0282(00)00518-5","volume":"73","author":"DK Gardner","year":"2000","unstructured":"Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril. 2000;73(6):1155\u20138.","journal-title":"Fertil Steril"},{"issue":"4","key":"3416_CR22","doi-asserted-by":"publisher","first-page":"103245","DOI":"10.1016\/j.rbmo.2023.06.002","volume":"47","author":"T Samarasekera","year":"2023","unstructured":"Samarasekera T, Willats E, Green MP, Hardy T, Rombauts L, Zander-Fox D. Impact of male age on paternal aneuploidy: single-nucleotide polymorphism microarray outcomes following blastocyst biopsy. Reprod Biomed Online. 2023;47(4):103245.","journal-title":"Reprod Biomed Online"},{"key":"3416_CR23","unstructured":"StataCorp. Stata Statistical Software: Release 18. College Station, TX: StataCorp LLC. 2023."},{"key":"3416_CR24","unstructured":"Victoria assisted reproductive treatment authority. VARTA Annual Report. Melbourne, Australia. 2022."},{"issue":"2","key":"3416_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/pd.6084","volume":"42","author":"N Vriesen","year":"2022","unstructured":"Vriesen N, Carmany EP, Natoli JL. Clinical outcomes of preimplantation genetic testing for hereditary cancer syndromes: a systematic review. Prenat Diagn. 2022;42(2):201\u201311.","journal-title":"Prenat Diagn"},{"key":"3416_CR26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fendo.2019.00094","volume":"10","author":"FM Ubaldi","year":"2019","unstructured":"Ubaldi FM, Cimadomo D, Vaiarelli A, Fabozzi G, Venturella R, Maggiulli R, et al. Advanced maternal age in IVF: still a challenge? The present and the future of its treatment. Front Endocrinol (Lausanne). 2019;10:94.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"3416_CR27","first-page":"101","volume":"3","author":"S Oehninger","year":"2011","unstructured":"Oehninger S. Poor responders in in vitro fertilization (IVF) therapy: the challenge continues. Facts Views Vis Obgyn. 2011;3(2):101\u20138.","journal-title":"Facts Views Vis Obgyn"},{"key":"3416_CR28","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fnmol.2017.00290","volume":"10","author":"L Man","year":"2017","unstructured":"Man L, Lekovich J, Rosenwaks Z, Gerhardt J. Fragile X-associated diminished ovarian reserve and primary ovarian insufficiency from molecular mechanisms to clinical manifestations. Front Mol Neurosci. 2017;10:290.","journal-title":"Front Mol Neurosci"},{"issue":"11","key":"3416_CR29","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.3390\/jpm12111781","volume":"12","author":"AD Archibald","year":"2022","unstructured":"Archibald AD, McClaren BJ, Caruana J, Tutty E, King EA, Halliday JL, et al. The Australian reproductive genetic carrier screening project (Mackenzie\u2019s Mission): design and implementation. J Pers Med. 2022;12(11):1781.","journal-title":"J Pers Med."},{"issue":"1","key":"3416_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41431-022-01218-3","volume":"31","author":"L Dive","year":"2023","unstructured":"Dive L, Freeman L, McEwen A. Genetic counsellors play a key role in supporting ethically responsible expanded universal carrier screening. Eur J Hum Genet. 2023;31(1):5\u20136.","journal-title":"Eur J Hum Genet"},{"issue":"11","key":"3416_CR31","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.3390\/genes14112069","volume":"14","author":"D Calosci","year":"2023","unstructured":"Calosci D, Passaglia L, Gabbiato I, Cartisano F, Affuso R, Sorrentino U, et al. Public awareness and acceptability of PGT-M in cancer predisposition syndromes. Genes (Basel). 2023;14(11):2069.","journal-title":"Genes (Basel)."},{"issue":"11","key":"3416_CR32","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1093\/humrep\/deac185","volume":"37","author":"L Cheng","year":"2022","unstructured":"Cheng L, Meiser B, Kirk E, Kennedy D, Barlow-Stewart K, Kaur R. Factors influencing patients\u2019 decision-making about preimplantation genetic testing for monogenic disorders. Hum Reprod. 2022;37(11):2599\u2013610.","journal-title":"Hum Reprod"},{"issue":"6","key":"3416_CR33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/MED.0000000000000440","volume":"25","author":"L Hawkins Bressler","year":"2018","unstructured":"Hawkins Bressler L, Steiner A. Anti-Mullerian hormone as a predictor of reproductive potential. Curr Opin Endocrinol Diabetes Obes. 2018;25(6):385\u201390.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"3416_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1757-2215-6-11","volume":"6","author":"A La Marca","year":"2013","unstructured":"La Marca A, Grisendi V, Giulini S, Argento C, Tirelli A, Dondi G, et al. Individualization of the FSH starting dose in IVF\/ICSI cycles using the antral follicle count. J Ovarian Res. 2013;6(1):11.","journal-title":"J Ovarian Res"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-025-03416-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-025-03416-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-025-03416-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T07:21:57Z","timestamp":1749885717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-025-03416-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["3416"],"URL":"https:\/\/doi.org\/10.1007\/s10815-025-03416-6","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"29 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was provided by the Human Research Ethics Committee of Monash Health (References number: RES-22\u2013000-178L). This study also had institutional approval from Monash IVF Group Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"AP and TH are paid employees of Monash IVF Group Ltd, providing clinical services to patients. At the time the study was performed, MM was also a paid employee of Monash IVF Group Ltd. AP receives a Monash IVF Group Ltd PhD support stipend. LH and SL have have no competing interests to declare that are relevant to the content of this article.The other funding bodies had no role in study design, data collection, analysis, interpretation, or writing of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}